8-Br-cGMP(8-Bromo-cGMP)

Modify Date: 2026-07-11 12:43:49

8-Br-cGMP(8-Bromo-cGMP) Structure
8-Br-cGMP(8-Bromo-cGMP) structure
Common Name 8-Br-cGMP(8-Bromo-cGMP)
CAS Number 51116-01-9 Molecular Weight 446.083
Density 2.96 g/cm3 Boiling Point 794.3ºC at 760 mmHg
Molecular Formula C10H10BrN5NaO7P Melting Point N/A
MSDS USA Flash Point 434.2ºC

 Use of 8-Br-cGMP(8-Bromo-cGMP)


8-Bromo-cGMP sodium, a membrane-permeable analogue of cGMP, is a PKG (protein kinase G) activator and significantly inhibits Ca2+ macroscopic currents and impairs insulin release stimulated with high K+[1]. 8-Bromo-cGMP sodium has antinociceptive effects[2].

 Names

This table lists Chinese names, IUPAC names and various aliases of this chemical substance.

Name 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt
Synonym More Synonyms

 8-Br-cGMP(8-Bromo-cGMP) Biological Activity

This table contains bioactivity, target information and biological‑assay experimental data of this compound.

Description 8-Bromo-cGMP sodium, a membrane-permeable analogue of cGMP, is a PKG (protein kinase G) activator and significantly inhibits Ca2+ macroscopic currents and impairs insulin release stimulated with high K+[1]. 8-Bromo-cGMP sodium has antinociceptive effects[2].
Target

PKG, Ca2+[1]

References

[1]. Sarkar O , et al. Nitric oxide attenuates overexpression of Giα proteins in vascular smooth muscle cells from SHR: Role of ROS and ROS-mediated signaling. PLoS One. 2017 Jul 10;12(7):e0179301.

[2]. Tegeder I , et al. Dual effects of spinally delivered 8-bromo-cyclic guanosine mono-phosphate (8-bromo-cGMP) in formalin-induced nociception in rats. Neurosci Lett. 2002 Oct 31;332(2):146-50.

 Chemical & Physical Properties

This table shows physicochemical parameters including melting point, boiling point, density, solubility and optical rotation. Missing data is marked as N/A.

Density 2.96 g/cm3
Boiling Point 794.3ºC at 760 mmHg
Molecular Formula C10H10BrN5NaO7P
Molecular Weight 446.083
Flash Point 434.2ºC
Exact Mass 444.939880
PSA 187.45000
LogP 0.25780
InChIKey FJAOOACZDYDVJT-YEOHUATISA-N
SMILES Nc1nc2c(nc(Br)n2C2OC3COP(=O)(O)OC3C2O)c(=O)[nH]1.[Na]

 MSDS

This table provides MSDS information including hazard classification, first‑aid, fire‑fighting, spill handling, operation and storage instructions.

 Safety Information

This table covers safety warnings, protective measures, incompatible substances and disposal guidelines for this compound.

Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
RIDADR NONH for all modes of transport

 Articles87

More Articles

This table lists relevant public references with title, journal and publication metadata for this compound.

Role of Telokin in Regulating Murine Gastric Fundus Smooth Muscle Tension.

PLoS ONE 10 , e0134876, (2015)

Telokin phosphorylation by cyclic GMP-dependent protein kinase facilitates smooth muscle relaxation. In this study we examined the relaxation of gastric fundus smooth muscles from basal tone, or pre-c...

Effects of caffeine on circadian phase, amplitude and period evaluated in cells in vitro and peripheral organs in vivo in PER2::LUCIFERASE mice.

Br. J. Pharmacol. 171(24) , 5858-69, (2014)

Caffeine is one of the most commonly used psychoactive substances. Circadian rhythms consist of the main suprachiasmatic nucleus (SCN) clocks and peripheral clocks. Although caffeine lengthens circadi...

Platelet-derived HMGB1 is a critical mediator of thrombosis.

J. Clin. Invest. 125 , 4638-54, (2015)

Thrombosis and inflammation are intricately linked in several major clinical disorders, including disseminated intravascular coagulation and acute ischemic events. The damage-associated molecular patt...

 8-Br-cGMP(8-Bromo-cGMP)Bioassay

View more

This table contains target information, in‑vitro & in‑vivo assay data for this compound.

Name: Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VER...
Source: ChEMBL
Target: Severe acute respiratory syndrome coronavirus 2
External Id: CHEMBL4513082
Name: Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Cac...
Source: ChEMBL
Target: Severe acute respiratory syndrome coronavirus 2
External Id: CHEMBL4303805
Name: SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response f...
Source: ChEMBL
Target: Replicase polyprotein 1ab
External Id: CHEMBL4495582
Total 3, Current Page 1 of 1
1

 Synonyms

This table collects all English aliases, systematic names and CAS‑related synonyms of the compound.

8-Br-cGMP 8-Bromo-cyclic GMP
EINECS 256-993-8
sodium 8-bromo-3',5'-cyclic GMP
Sodium (4aR,6R,7R,7aS)-6-(2-amino-8-bromo-6-oxo-1,6-dihydro-9H-purin-9-yl)-7-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate 2-oxide
8-Bromo-cGMP, sodium salt,8-Bromoguanosinecyclic3',5'-monophosphatesodiumsalt
6H-Purin-6-one, 2-amino-8-bromo-1,9-dihydro-9-[(4aR,6R,7R,7aS)-tetrahydro-2,7-dihydroxy-2-oxido-4H-furo[3,2-d]-1,3,2-dioxaphosphorin-6-yl]-, sodium salt (1:1)
MFCD00070128

 8-Br-cGMP(8-Bromo-cGMP) | FAQ

This section contains frequently‑asked‑questions about this compound, including basic parameters, properties, storage conditions and corresponding answers.

Q: What is the molecular formula of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt?
A: Molecular formula of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt is C10H10BrN5NaO7P.
Q: What is the polar surface area (PSA) of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt?
A: Polar surface area (PSA) of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt is 187.45000.
Q: What is the SMILES notation of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt?
A: SMILES notation of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt is Nc1nc2c(nc(Br)n2C2OC3COP(=O)(O)OC3C2O)c(=O)[nH]1.[Na].
Q: What is the LogP of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt?
A: LogP of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt is 0.25780.
Q: What is the English name of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt?
A: The English name of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt is 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt.
Q: What is the CAS number of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt?
A: CAS number of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt is 51116-01-9.
Q: What is the molecular weight of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt?
A: Molecular weight of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt is 446.083.
Q: What is the InChIKey of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt?
A: InChIKey of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt is FJAOOACZDYDVJT-YEOHUATISA-N.
Q: What are the uses of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt?
A: Main uses of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt: 8-Bromo-cGMP sodium, a membrane-permeable analogue of cGMP, is a PKG (protein kinase G) activator and significantly inhibits Ca2+ macroscopic currents and impairs insulin release stimulated with high K+[1]. 8-Bromo-cGMP sodium has antinociceptive effects[2].
Q: What is the boiling point of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt?
A: Boiling point of 8-Bromoguanosine 3′,5′-cyclic monophosphate sodium salt is 794.3ºC at 760 mmHg.

 8-Br-cGMP(8-Bromo-cGMP)factory

This table lists manufacturers and suppliers of this compound, including vendor names and product supply reference information.

Shanghai Nianxing Industrial Co., Ltd
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.